Skip to main content

Table 3 Treatment administered to children with Talaromyces marneffei infections

From: Talaromyces marneffei infection and complicate manifestation of respiratory system in HIV-negative children

Patient

Antifungal therapy

Treatment of combined infection and underlying diseases

Antifungal course (month)

Outcome

P1

voriconazole + amphotericin B + itraconazole

None

51

Improved

P2

voriconazole + itraconazole

None

12

No follow-up

P3

voriconazole + itraconazole

None

12

Improved

P4

voriconazole + itraconazole

Compound sulfamethoxazole

12

Improved

P5

amphotericin B + voriconazole + itraconazole

Regular intravenous

Immunoglobulin, Compound sulfamethoxazole

6

No follow-up

P6

amphotericin B + voriconazole + itraconazole

Compound sulfamethoxazole, hemophagocytic lymphohistiocytosis treatment

12

Improved